Fox Chase Cancer Center News

PHILADELPHIA (August 3, 2015) – Joseph R. Testa, PhD, professor and Carol and Kenneth E. Weg Chair of Human Genetics at Fox Chase Cancer Center, has been appointed to serve as senior editor for Cancer Research, a journal of the American Association for Cancer Research.

PHILADELPHIA (August 3, 2015) – Pankaj Sharda, MD, has joined the Department of Medicine, Endocrinology Division, as an attending physician, where he specializes in endocrinology, diabetes and metabolism.

PHILADELPHIA (July 21, 2015)—Fox Chase Cancer Center has been ranked 21st among the nation’s top 50 hospitals for cancer care in U.S. News & World Report’s Best Hospitals 2015-2016 rankings. Fox Chase was also cited as high performing in the areas of urology; gynecology; and ear, nose, and throat.

PHILADELPHIA (July 16, 2015) — Get Your Rear in Gear Philadelphia awarded Fox Chase Cancer Center a grant for $25,000 for, “Understanding Quality of Life Issues Following Recovery from Colon Cancer Treatment.”  The money for this grant comes from funds that were raised during the 2015 Get Your Rear in Gear in Philadelphia.

HUMMELSTOWN, PA (July 13, 2015) – Oncoceutics and Fox Chase Cancer Center have announced an agreement to conduct clinical testing with ONC201, a novel first-in-class small molecule compound being developed by the company. The study  will systematically assess dose escalation with three different schedules for oral ONC201 ranging from every three week to one week administration.

PHILADELPHIA, PA (June 24, 2015) – State Rep. Angel Cruz is inviting eligible constituents to his district office for a breast cancer screening held in coordination with the Fox Chase Cancer Center Mobile Mammography Van. Thursday, July 9, 2015.

PHILADELPHIA (June 12, 2015) — Because of its location, cancers on the pancreas may invade and wrap around nearby veins and arteries in the abdomen. When these vessels become involved, surgery to remove the cancer, which is typically the standard treatment, becomes significantly more difficult and sometimes impossible. Researchers at Fox Chase Cancer Center have identified a way to safely shrink the tumor, pulling it away from these vessels and allowing patients to undergo potentially curative surgery.

IRVING, TX (June 10, 2015) — Caris Life Sciences®, a leading biotechnology company focused on fulfilling the promise of precision medicine, today announced it has designated Fox Chase Cancer Center a center of excellence site in the Caris Centers of Excellence for Precision Medicine Network™ (Network).